I'm LongbridgeAI, I can summarize articles.Cryoport (CYRX.US) surged nearly 13% during regular trading to $18.10.
The company reported fiscal 2026 third-quarter revenue of $50.2 million, up 14% from a year earlier and topping the analyst consensus of $48.8 million. Adjusted EBITDA turned positive at $1.1 million, beating estimates of $551,000. Cryoport raised its full-year 2026 revenue guidance to $197 million to $199 million, though third-quarter net loss widened 56% year-over-year to $10.85 million.
Separately, Cryoport's Paris center received ISO certification, and management highlighted strategic expansion in bioservices capacity.
Based on public media reports. AI-generated; not investment advice.
